The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for CTx-1301 for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adults.
Money Talks News on MSN
Parents Warned As Children Take ADHD Drugs for Years With Limited Safety Research
The average ADHD medication treatment for children exceeds three years while safety data only covers one year. Boys starting ...
With school counselors outnumbered and mental health workers overloaded, can AI chatbots help students with immediate needs ...
Members of the Neu Narrative support group say they, or their children, have waited years for a diagnosis and have been ...
Like many adult women struggling to find answers in the medical system, Kristen Einarson was first “diagnosed” with ADHD, or ...
Parenting a child with Attention Deficit Hyperactivity Disorder (ADHD) can be incredibly challenging. The endless demands, coupled with the unpredictable nature of the disorder, can create a chaotic ...
Hours after shutting down potential drama about their respective beauty brands, Selena Gomez and Hailey Bieber each stepped out at the 2025 Academy Museum Gala. Gomez, 33, attended the benefit on ...
A Tasmanian teenager who held up a liquor store with a 20-centimetre knife has avoided jail, in what a judge described as a ...
Global mortality continues to fall. Life expectancy has improved to unprecedented levels and deaths in young children have ...
A professional psychiatrist has revealed the telltale signs he frequently observes in women living with Attention Deficit ...
A professional psychiatrist has revealed the telltale signs he frequently observes in women living with Attention Deficit ...
Open-access publication demonstrates the validity and reliability of the Mentavi online Diagnostic Evaluation compared to a clinical interview, widening evidence based telehealth access for adults ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果